<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17491" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Amylase</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Akinfemiwa</surname>
            <given-names>Ololade</given-names>
          </name>
          <aff>St. George's University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zubair</surname>
            <given-names>Muhammad</given-names>
          </name>
          <aff>Indus Hospital &#x00026; Health Network</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Muniraj</surname>
            <given-names>Thiruvengadam</given-names>
          </name>
          <aff>Yale University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ololade Akinfemiwa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Zubair declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Thiruvengadam Muniraj declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>11</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17491.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Amylase is a digestive enzyme predominantly secreted by the pancreas and salivary glands and is present in other tissues at minimal levels.<xref ref-type="bibr" rid="article-17491.r1">[1]</xref> Amylase was initially described in the early 1800s and is one of the pioneering enzymes to undergo scientific investigation. Although this enzyme was originally termed <italic toggle="yes">diastaste</italic>, it was later renamed "amylase" in the early 20th century.<xref ref-type="bibr" rid="article-17491.r2">[2]</xref></p>
        <p>The primary role of amylases is to break down the glycosidic bonds within starch molecules, transforming complex carbohydrates into simpler sugars. Amylase enzymes are categorized into 3 main classes&#x02014;alpha-, beta-, and gamma amylases&#x02014;each targeting distinct segments of the carbohydrate molecule.<xref ref-type="bibr" rid="article-17491.r2">[2]</xref> Alpha amylase is present in humans, animals, plants, and microbes, whereas beta amylase is primarily found in microbes and plants. Gamma amylase, on the other hand, can be located in both animals and plants.<xref ref-type="bibr" rid="article-17491.r3">[3]</xref></p>
        <p>In 1908, a study by Wohlgemuth identified the presence of amylase in urine, paving the way for its application as a diagnostic laboratory test. Amylase is a frequently ordered standard diagnostic test, often combined with lipase, particularly when acute pancreatitis is suspected in patients.<xref ref-type="bibr" rid="article-17491.r2">[2]</xref></p>
      </sec>
      <sec id="article-17491.s2" sec-type="Etiology and Epidemiology">
        <title>Etiology and Epidemiology</title>
        <p>Elevated amylase levels may manifest in various conditions, including pancreatic, salivary, and intestinal diseases, as well as decreased metabolic clearance and macroamylasemia.<xref ref-type="bibr" rid="article-17491.r4">[4]</xref> Approximately 11% to 13% of patients experiencing non-pancreatic abdominal pain exhibit elevated pancreatic enzyme levels.<xref ref-type="bibr" rid="article-17491.r5">[5]</xref>&#x000a0;On at least one occasion, 60% of asymptomatic HIV-positive patients displayed abnormal amylase or lipase measurements.<xref ref-type="bibr" rid="article-17491.r6">[6]</xref> Upon admission, 26 out of 208 patients (12.5%) with acute abdominal pain unrelated to pancreatic issues presented with elevated serum amylase levels.<xref ref-type="bibr" rid="article-17491.r5">[5]</xref></p>
        <p>Abnormally elevated amylase levels are observed in 35% of patients with liver disease.<xref ref-type="bibr" rid="article-17491.r7">[7]</xref> Furthermore, elevated amylase levels are found in around 16% to 25% of diabetic ketoacidosis cases.<xref ref-type="bibr" rid="article-17491.r8">[8]</xref><xref ref-type="bibr" rid="article-17491.r9">[9]</xref>&#x000a0;In a group of 74 patients with surgically resectable lung cancer, 13 showed hyperamylasemia.<xref ref-type="bibr" rid="article-17491.r10">[10]</xref></p>
      </sec>
      <sec id="article-17491.s3" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Amylase is a heterogeneous calcium-dependent metalloenzyme with a diverse molecular weight range, typically between 54 and 62 kDa. The compact size of amylase facilitates efficient filtration through the glomeruli.<xref ref-type="bibr" rid="article-17491.r1">[1]</xref> Amylase is eliminated through both the renal system and the reticuloendothelial system.<xref ref-type="bibr" rid="article-17491.r3">[3]</xref>&#x000a0;This enzyme exists as 2 isoenzymes&#x02014;pancreatic (P-type) and nonpancreatic (S-type)&#x02014;which are products of 2 closely linked loci on chromosome 1. Additional amylase heterogeneity results from allelic variation, with 12 alleles for the S-type and 6 alleles for the P-type.<xref ref-type="bibr" rid="article-17491.r11">[11]</xref> Both types of amylase also undergo post-translational modifications involving deamidation, glycosylation, and deglycosylation, giving rise to various isoforms. Amylase exhibits a broad tissue distribution, with the most significant levels of P- and S-type activities being found in the exocrine pancreas and salivary glands, respectively.<xref ref-type="bibr" rid="article-17491.r12">[12]</xref></p>
        <p>P-type amylase is synthesized by pancreatic acinar cells and released into the intestinal tract through the pancreatic duct system. The enzymatic activity of P-type amylase is optimized under the slightly alkaline conditions of the duodenum.<xref ref-type="bibr" rid="article-17491.r13">[13]</xref>&#x000a0;Meanwhile, the salivary glands host the highest S-type amylase activity, initiating starch hydrolysis during mastication in the mouth and the passage through the esophagus. However, this action is terminated upon exposure to stomach acid.</p>
        <p>S-type amylase is also detectable in extracts from testes, ovaries, fallopian tubes, Mullerian ducts, striated muscle, lungs, and adipose tissue, as well as in bodily fluids such as semen, colostrum, tears, and milk. Approximately 25% of plasma amylase is excreted by the kidneys, with the majority being reabsorbed within the proximal tubules.<xref ref-type="bibr" rid="article-17491.r14">[14]</xref>&#x000a0;The liver is believed to be the primary organ responsible for amylase elimination, leading to a half-life of approximately 10 hours. Serum amylase is intricately controlled within the body,<xref ref-type="bibr" rid="article-17491.r15">[15]</xref> with a delicate balance between its production and clearance rates.&#x000a0;Elevated amylase levels can result from heightened production, whether originating in the pancreas or outside it, or from a diminished clearance rate.</p>
        <p>Genetic regulation is likely to play a crucial role in the preliminary determination of salivary amylase.<xref ref-type="bibr" rid="article-17491.r1">[1]</xref>&#x000a0;In newborns, the predominant amylase isozymes detected in urine originate from saliva, and as development progresses, both salivary and pancreatic amylase isozymes become more prominent. The functional integrity of amylase is entirely dependent on the presence of calcium.<xref ref-type="bibr" rid="article-17491.r16">[16]</xref>&#x000a0;However, complete functionality is achieved only in the presence of specific anions, including chloride, bromide, nitrate, or monohydrogen phosphate. Chloride and bromide are the most effective activators. The pH optimum for amylase activity falls within the range of 6.9 to 7.0.<xref ref-type="bibr" rid="article-17491.r17">[17]</xref></p>
        <p>The analyte amylase is an endoglycosidase enzyme belonging to the hydrolase class, and it catalyzes the hydrolysis of 1,4-&#x003b1;-glucosidic linkages between adjacent glucose units&#x000a0;in complex carbohydrates.<xref ref-type="bibr" rid="article-17491.r18">[18]</xref>&#x000a0;Notably, straight-chain (linear) polyglucans, such as amylose, and branched-chain polyglucans, such as amylopectin and glycogen, are hydrolyzed at different rates.<xref ref-type="bibr" rid="article-17491.r19">[19]</xref>&#x000a0;In the case of amylose, the enzyme cleaves the chains at alternate &#x003b1;-1,4-hemiacetal (-C-O-C-) links, thereby forming maltose and some residual glucose. In the case of branched polyglucans, the enzyme generates maltose, glucose, and a residue of limit dextrins. Notably, the enzyme does not target the &#x003b1;-1,6-linkages at the branch points.<xref ref-type="bibr" rid="article-17491.r2">[2]</xref></p>
      </sec>
      <sec id="article-17491.s4" sec-type="Specimen Requirements and Procedure">
        <title>Specimen Requirements and Procedure</title>
        <p>Either serum or heparinized plasma can serve as suitable samples. Nevertheless, a particular study indicated that when using dry-film technology for measurement, heparinized plasma samples yielded significantly higher results than serum samples.<xref ref-type="bibr" rid="article-17491.r20">[20]</xref>&#x000a0;As amylase has an absolute requirement for calcium ions, it is noteworthy that chelating anticoagulants, such as citrate, oxalate, and EDTA, cannot be used when&#x000a0;collecting plasma for amylase measurements. However, urine specimens without preservatives, obtained through random or timed collections, are considered valid samples.</p>
        <p>Amylase is occasionally measured in ascitic, peritoneal, or pleural fluid, and its presence in these fluids can suggest pancreatitis or the presence of a tumor. In serum, amylase activity remains stable for up to 4 days at room temperature, 2 weeks at 5 &#x000b0;C, 1 year at &#x02212;28 &#x000b0;C, or 5 years at &#x02212;75 &#x000b0;C. Urine specimens should be analyzed within 12 hours at room temperature or within 5 days when stored at 5 &#x000b0;C.&#x000a0;Notably, urine should not be subjected to freezing.<xref ref-type="bibr" rid="article-17491.r21">[21]</xref></p>
      </sec>
      <sec id="article-17491.s5" sec-type="Diagnostic Tests">
        <title>Diagnostic Tests</title>
        <p>Over the years, amylase has played a central role in diagnosing acute pancreatitis. Amylase can be assessed through either a blood test or a urine test. In the case of a urine test, it can be conducted through a clean catch or a 24-hour urine collection.<xref ref-type="bibr" rid="article-17491.r3">[3]</xref>&#x000a0;The normal range for serum amylase can vary between different laboratories. Notably, it is clinically significant to differentiate pancreatic amylase from other amylase isoforms. If amylase levels are elevated while lipase remains within the normal range, it might indicate an issue originating outside the pancreas.<xref ref-type="bibr" rid="article-17491.r15">[15]</xref></p>
        <p>The lipase-to-amylase ratio may help distinguish between gallstone-induced pancreatitis and alcoholic pancreatitis. Gallstones tend to cause more significant elevations in amylase levels, whereas alcohol typically results in higher elevations in lipase levels. A lipase-to-amylase ratio exceeding 2 exhibits 91% sensitivity and 76% specificity for diagnosing alcoholic pancreatitis, whereas a ratio exceeding 5 demonstrates 31% sensitivity and nearly 100% specificity for identifying alcoholic pancreatitis.<xref ref-type="bibr" rid="article-17491.r22">[22]</xref> Elevated alanine transaminase levels reaching 3 times the normal range are highly specific for diagnosing gallstone pancreatitis. Although the combined measurement of serum amylase and lipase enhances specificity compared to either test in isolation, it does not notably improve sensitivity.<xref ref-type="bibr" rid="article-17491.r23">[23]</xref></p>
      </sec>
      <sec id="article-17491.s6" sec-type="Testing Procedures">
        <title>Testing Procedures</title>
        <p>The amylase test is conducted using semiautomatic or fully automated analyzers that operate on the principles of photometry. Photometry entails the measurement of light absorption across the ultraviolet (UV), visible (VIS), and infrared (IR) spectrum. This measurement is used to quantify the concentration of an analyte in a solution or liquid. Photometers utilize a specific light source and detectors, such as photodiodes, photoresistors, or photomultipliers, to transform the light transmitted through a sample solution into a corresponding electrical signal. Photometry applies Beer&#x02013;Lambert law to calculate coefficients obtained from the transmittance measurement.<xref ref-type="bibr" rid="article-17491.r24">[24]</xref> A test-specific calibration process is utilized to establish a correlation between the absorbance and analyte concentration to achieve highly accurate measurements.<xref ref-type="bibr" rid="article-17491.r25">[25]</xref></p>
        <p>P-type amylase can be differentiated from S-type amylase by selective inhibition of S-type using a wheat germ inhibitor, temperature inhibition, immunoprecipitation, or immunoinhibition with a monoclonal antibody. However, only the methods based on selective inhibition by monoclonal antibodies have demonstrated adequate precision, reliability, practicality, and analytical speed, enabling the reliable measurement of P-type amylase.<xref ref-type="bibr" rid="article-17491.r26">[26]</xref>&#x000a0;The amylase isoforms can be separated by isoelectric focusing, ion-exchange chromatography, or gel/capillary electrophoresis by electrophoretic endosmosis.<xref ref-type="bibr" rid="article-17491.r27">[27]</xref></p>
      </sec>
      <sec id="article-17491.s7" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>Amylase assays typically resist hemoglobin, bilirubin, or triglyceride interference. However, collecting specimens in tubes containing oxalate, citrate, or EDTA may result in falsely decreased values due to the chelation of necessary amylase cofactors.<xref ref-type="bibr" rid="article-17491.r3">[3]</xref> Certain medications, such as aspirin, morphine, antiretrovirals, and estrogen-containing drugs, can potentially&#x000a0;affect serum amylase levels.<xref ref-type="bibr" rid="article-17491.r28">[28]</xref></p>
        <p>Elevated amylase activity in serum can be attributed to a condition known as macroamylasaemia, which is characterized by the formation of macromolecular complexes. These complexes typically involve immunoglobulins&#x02014; predominantly IgA or IgG&#x02014;although self-polymerization or association with other proteins can also occur.<xref ref-type="bibr" rid="article-17491.r29">[29]</xref> Typically, these complexes maintain their enzymatic activity but cannot be effectively filtered by the renal glomeruli. As a result, this condition leads to delayed clearance and increased serum amylase activity.<xref ref-type="bibr" rid="article-17491.r30">[30]</xref>&#x000a0;This benign condition has been reported in up to 1.5% of hospitalized patients, accounting for as much as 28% of chronic and otherwise unexplained hyperamylasemia cases.<xref ref-type="bibr" rid="article-17491.r31">[31]</xref>&#x000a0;</p>
        <p>Macroamylasaemia is a condition associated with autoimmunity, malignancy, cardiovascular disease, diabetes mellitus, and malabsorptive disorders. Macroamylasemia should be considered when evaluating asymptomatic patients with elevated serum amylase levels.<xref ref-type="bibr" rid="article-17491.r32">[32]</xref>&#x000a0;Notably, no specific treatment is&#x000a0;mandated for this condition, as it is typically benign.<xref ref-type="bibr" rid="article-17491.r33">[33]</xref>&#x000a0;</p>
        <p>The&#x000a0;circulating pancreatic amylase levels are higher in female subjects with O blood type than those with A blood&#x000a0;type, where pancreatic amylase levels tend to be lower.<xref ref-type="bibr" rid="article-17491.r34">[34]</xref>&#x000a0;Psychosocial stress contributes to elevated salivary amylase levels even in healthy individuals, potentially resulting in higher total serum amylase. However, it remains unconfirmed through clinical studies whether psychosocial stress has a long-term effect on serum amylase levels.<xref ref-type="bibr" rid="article-17491.r35">[35]</xref></p>
        <p>In pancreatitis accompanied by hypertriglyceridemia cases, serum amylase levels may mistakenly appear within the normal range. This discrepancy is linked to an inhibitor associated with elevated triglycerides, which interferes with the assay for the enzyme. By diluting the serum, the inhibitory effect can be lessened, allowing for a recalculation of serum amylase levels to reveal the actual concentration.<xref ref-type="bibr" rid="article-17491.r36">[36]</xref></p>
      </sec>
      <sec id="article-17491.s8" sec-type="Results, Reporting, and Critical Findings&#x0000d;&#x0000a;">
        <title>Results, Reporting, and Critical Findings
</title>
        <p>The reference intervals for amylase can vary among different assay methods due to variations in the substrates used and reagent preparations.<xref ref-type="bibr" rid="article-17491.r37">[37]</xref>&#x000a0;A patient's blood test values should be interpreted based on the reference values established by the specific laboratory conducting the test. Furthermore, it is recommended for each laboratory to establish its unique reference interval based on its specific testing methodology.<xref ref-type="bibr" rid="article-17491.r38">[38]</xref>&#x000a0;A significant proportion of subjects of African and Asian origin exhibit S-type amylase activity levels exceeding the reference interval established for white populations. This can lead to an elevated total amylase measurement without indicating any pathological condition.<xref ref-type="bibr" rid="article-17491.r39">[39]</xref></p>
        <p>The blood amylase activity in newborns is approximately 18% of that in adults. Serum amylase activity does not show significant differences between males and females. In healthy adults, P-AMY typically accounts for about 40% to 50% of the total amylase activity in serum. In most children less than 6 months of age, serum P-AMY activity is not detectable. However, its activity gradually increases after this period and reaches adult concentrations by the age of 5, which corresponds to the postnatal development of exocrine pancreatic function.<xref ref-type="bibr" rid="article-17491.r40">[40]</xref> Therefore, using this enzyme for diagnosing acute pancreatitis in young children should be avoided.<xref ref-type="bibr" rid="article-17491.r41">[41]</xref></p>
        <p>Currently, there is no internationally standardized reference range for amylase levels, with the reference range varying from as low as 20 U/L to as high as 300 U/L. However, elevated amylase levels exceeding 3 times the&#x000a0;upper limit of normal (URL) strongly indicate the likelihood of acute pancreatitis.<xref ref-type="bibr" rid="article-17491.r42">[42]</xref> Amylase levels below this threshold are associated with other medical conditions. Abnormally low amylase levels, while less common, can be observed in conditions such as cystic fibrosis, chronic pancreatitis, diabetes mellitus, obesity, and among individuals who smoke.<xref ref-type="bibr" rid="article-17491.r43">[43]</xref>&#x000a0;Clinicians should be aware of such potential causes when interpreting low amylase activity in patients.<xref ref-type="bibr" rid="article-17491.r44">[44]</xref></p>
        <p>A finding of persistently elevated total amylase and normal lipase should raise the possibility of macroamylasemia. Screening tests such as the amylase creatinine clearance ratio (ACCR) or polyethylene glycol precipitation can be valuable in identifying macroamylase.<xref ref-type="bibr" rid="article-17491.r45">[45]</xref>&#x000a0;ACCR can be easily calculated from paired random urine and serum amylase and creatinine measurements. Although an ACCR lower than 1% indicates the possibility of macroamylasemia, each laboratory needs to assess the suitability of these expected values for its unique patient population and, if required, establish its own reference ranges.<xref ref-type="bibr" rid="article-17491.r46">[46]</xref>&#x000a0;An ACCR value greater than 5% suggests acute pancreatitis.<xref ref-type="bibr" rid="article-17491.r47">[47]</xref>&#x000a0;Notably, the ACCR is also known to be increased in diabetic ketoacidosis, renal disease, and after surgical procedures.<xref ref-type="bibr" rid="article-17491.r48">[48]</xref></p>
      </sec>
      <sec id="article-17491.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Amylase is primarily used for diagnosing pancreatic diseases and is a frequently measured enzyme owing to the accessibility of cost-effective and readily automated methods. Although amylase is a sensitive marker for acute pancreatitis, its lack of specificity is evident, as it can be elevated in numerous conditions unrelated to the pancreas.<xref ref-type="bibr" rid="article-17491.r49">[49]</xref> Pancreatitis can be defined by the presence of at least 2 out of the 3 criteria&#x02014;abdominal pain, serum amylase, and/or lipase levels&#x02014;exceeding 3 times the URL and characteristic findings of pancreatitis on abdominal imaging. Therefore, the clinical significance of amylase has been a subject of inquiry.<xref ref-type="bibr" rid="article-17491.r50">[50]</xref>&#x000a0;In cases of elevated amylase levels and insufficient evidence of pancreatitis, healthcare professionals should contemplate alternative causes of hyperamylasemia.<xref ref-type="bibr" rid="article-17491.r51">[51]</xref>&#x000a0;</p>
        <p>Amylase does not help predict the severity of an acute pancreatic episode or for monitoring the condition.&#x000a0;The magnitude of the increase in serum enzyme activity is not correlated with the severity of pancreatic involvement. However, a more substantial rise in amylase levels does increase the probability of acute pancreatitis. The limited specificity of total amylase measurement has spurred interest in directly measuring P-type amylase, rather than total enzyme activity, for the differential diagnosis of patients experiencing acute abdominal pain.<xref ref-type="bibr" rid="article-17491.r19">[19]</xref> Utilizing the best decision limit, which corresponds to an activity 3 times the URL, the specificity of P-type amylase in diagnosing acute pancreatitis exceeds 90%. Furthermore, P-AMY significantly enhances sensitivity in the late detection of this condition. One week after onset, P-type amylase values remain elevated in 80% of patients with uncomplicated pancreatitis, while only 30% still exhibit increased total amylase activity.<xref ref-type="bibr" rid="article-17491.r52">[52]</xref>&#x000a0;This long-standing increase in&#x000a0;P-type amylase activity in serum renders the traditional measurement of total amylase in urine redundant. This test is performed to achieve better diagnostic sensitivity in the late phase of pancreatitis.<xref ref-type="bibr" rid="article-17491.r53">[53]</xref></p>
        <p>Amylase inhibitors such as acarbose have been used in treating type 2 diabetes and have demonstrated the ability to lower hemoglobin A1C levels and reduce peak postprandial glucose. Acarbose has also proven effective in enhancing the remission of dumping syndrome in patients who have undergone bariatric procedures. In addition, this drug has demonstrated the capacity to reduce the risk of cardiovascular disease by slowing the progression of carotid artery thickening.<xref ref-type="bibr" rid="article-17491.r54">[54]</xref> Elevated amylase levels can be observed in a wide array of conditions. Therefore, clinicians need to follow a well-defined, systematic approach when hyperamylasemia is detected. This approach can prevent unnecessary hospitalization and ensure timely and appropriate treatment.<xref ref-type="bibr" rid="article-17491.r55">[55]</xref> Biliary tract diseases, including cholecystitis, can lead to up to a 4-fold increase in serum P-type amylase activity due to primary or secondary pancreatic involvement.<xref ref-type="bibr" rid="article-17491.r56">[56]</xref></p>
        <p>Various intra-abdominal events can result in a substantial rise in serum P-type amylase activities, often reaching up to 4-fold or even greater. These elevations may be attributed to the leakage of P-type amylase from the intestine into the peritoneal cavity and subsequently into the circulation.<xref ref-type="bibr" rid="article-17491.r57">[57]</xref> In cases of renal insufficiency, serum amylase activity increases proportionally with the degree of renal impairment, typically not exceeding 5 times the URL.<xref ref-type="bibr" rid="article-17491.r58">[58]</xref></p>
        <p>Cases of amylase-producing multiple myeloma have been described. Increased amylase activity in most patients results from salivary-type hyperamylasemia&#x02014;sialyl salivary type.<xref ref-type="bibr" rid="article-17491.r59">[59]</xref>&#x000a0;A common feature of the myeloma cell lines associated with hyperamylasemia is&#x000a0;the presence of a chromosome 1 translocation, which harbors the gene for amylase. The link does not seem to be specific to any particular immunoglobulin class. The onset of hyperamylasemia is reported to be associated with rapid disease progression, extensive bone destruction, and increased mortality. Consequently, serum amylase activity may serve as a valuable prognostic "tumor marker" in patients with multiple myeloma, with activity decreasing in response to treatment and increasing during periods of relapse.<xref ref-type="bibr" rid="article-17491.r60">[60]</xref><xref ref-type="bibr" rid="article-17491.r61">[61]</xref> The amylase isoenzyme in cases of ruptured ectopic pregnancy is not well characterized. In severe cases that are diagnosed late, the elevated isoenzyme may be P-AMY due to pancreatic involvement associated with peritonitis, despite the presence of S-AMY in the fallopian tube.<xref ref-type="bibr" rid="article-17491.r62">[62]</xref></p>
        <p>In some cases, patients with pheochromocytoma or paraganglioma exhibit hyperamylasemia, usually the salivary isotype. In these instances, hyperamylasemia might be associated with a hypertensive crisis and vasoconstriction, resulting in tissue hypoxia rather than being a consequence of tumor secretion. This elevation in amylase activity is often transient.<xref ref-type="bibr" rid="article-17491.r63">[63]</xref>&#x000a0;Salivary-type hyperamylasemia has been documented in various conditions unrelated to salivary gland disorders. These include diabetic ketoacidosis, pneumonia, and postoperative states following a diverse array of surgical procedures, including extra abdominal procedures such as postcoronary bypass.<xref ref-type="bibr" rid="article-17491.r64">[64]</xref></p>
        <p>Benign pancreatic hyperenzymemia or Gullo syndrome was first described by Lucio Gullo and is characterized by elevated serum levels of amylase, pancreatic isoamylase, lipase, and trypsin activities in asymptomatic individuals with no evidence of pancreatic disease on imaging. The syndrome occurs sporadically or in a familial form, and amylase activity may exhibit notable fluctuations, occasionally normalizing transiently in some cases.<xref ref-type="bibr" rid="article-17491.r65">[65]</xref> The etiology of benign pancreatic hyperenzymemia does not appear to involve <italic toggle="yes">CFTR</italic>, <italic toggle="yes">SPINK1</italic>, or <italic toggle="yes">PRSS1</italic> gene mutations. In addition, this condition cannot be attributed to mutations in genes known to be associated with pancreatitis or other <italic toggle="yes">PRSS1</italic>/<italic toggle="yes">SPINK1</italic> genes.<xref ref-type="bibr" rid="article-17491.r66">[66]</xref> Researchers discovered that approximately one-third of patients with chronic non-pathological pancreatic hyperenzymemia had notably elevated fecal calprotectin concentrations. They recommended investigating this discovery to explore the potential connection between intestinal ecology and alterations in pancreatic enzymes.<xref ref-type="bibr" rid="article-17491.r67">[67]</xref></p>
        <p>Damage of salivary glands, leading to salivary hyperamylasemia, has been observed following trauma or surgical procedures on the salivary gland. Furthermore, radiation to the neck area involving the parotid gland can lead to duct obstruction or calculi formation in the salivary glands.<xref ref-type="bibr" rid="article-17491.r14">[14]</xref> Chronic alcoholism and anorexia nervosa can also lead to subclinical damage to the salivary glands. In individuals with alcoholism, 10% of patients exhibit salivary amylase activity, which is 3 times higher than normal and may be associated with chronic liver disease.<xref ref-type="bibr" rid="article-17491.r68">[68]</xref></p>
        <p>Hyperamylasemia in anorexia nervosa is associated with vomiting, and the detection of elevated salivary amylase levels may hint at concealed vomiting.<xref ref-type="bibr" rid="article-17491.r69">[69]</xref>&#x000a0;However, pancreatitis can develop in these patients, especially during the refeeding process. Therefore, it may be warranted to measure plasma lipase and/or amylase isoenzymes to distinguish between pancreatitis and salivary hyperamylasemia.<xref ref-type="bibr" rid="article-17491.r70">[70]</xref></p>
        <p>Hyperamylasemia may be associated with various tumors, either due to ectopic production of the enzyme by the tumors or possibly as an inflammatory response by the tumor cells, thereby leading to the significant release of the enzyme normally produced in these tissues into the bloodstream.<xref ref-type="bibr" rid="article-17491.r71">[71]</xref>&#x000a0;The raised isoenzyme is almost exclusively salivary type in ovarian, lung cancer, multiple myeloma, and pheochromocytoma.<xref ref-type="bibr" rid="article-17491.r72">[72]</xref>&#x000a0;Amylase-producing tumors of the lung are rare, accounting for only 1% to 3% of all lung carcinomas, and in such instances, the salivary amylase isotype is typically present. These amylase-producing lung carcinomas are primarily adenocarcinomas, although hyperamylasemia has also been documented in cases of small-cell carcinoma.<xref ref-type="bibr" rid="article-17491.r73">[73]</xref>&#x000a0;Amylase activity has been suggested as a valuable tumor marker for monitoring the patient's treatment in amylase-producing lung carcinoma cases.<xref ref-type="bibr" rid="article-17491.r74">[74]</xref> In one study, it was noted that 39% of patients with ovarian carcinoma exhibited hyperamylasemia, primarily of the salivary type, suggesting that salivary amylase could be a useful indicator for assessing the effectiveness of radiotherapy in this context.<xref ref-type="bibr" rid="article-17491.r75">[75]</xref></p>
        <p>Gut diseases, including mucosal inflammatory disease of the small intestine, mesenteric infarction, intestinal obstruction, appendicitis, and peritonitis, generally lead to elevated P-type isoamylase levels due to increased absorption of amylase from the intestinal lumen.<xref ref-type="bibr" rid="article-17491.r76">[76]</xref>&#x000a0;Gut perforation is associated with the leakage of intestinal contents into the peritoneum, leading to inflammation and the absorption of amylase across the inflamed peritoneum, which can result in hyperamylasemia. Acidosis can lead to hyperamylasemia and may arise from 2 sources&#x02014;ketoacidosis, which results in increased S-type and P-type isoamylases, or nonketotic acidosis, which leads to increased S-type isoamylase.<xref ref-type="bibr" rid="article-17491.r77">[77]</xref> Postoperative amylase increases can lead to elevated S-type and P-type isoamylase levels, with a more common increase observed in salivary amylase.<xref ref-type="bibr" rid="article-17491.r78">[78]</xref>&#x000a0;This elevation may occur after procedures involving extracorporeal circulation or nonabdominal surgery. For instance, approximately 30% of patients undergoing cardiac surgery exhibit elevated S-type isoamylase.<xref ref-type="bibr" rid="article-17491.r79">[79]</xref></p>
        <p>Rare cases of hyperamylasemia have been reported in association with systemic lupus erythematosus, as well as with ciprofloxacin treatment.<xref ref-type="bibr" rid="article-17491.r80">[80]</xref>&#x000a0;Additional causes contributing to hyperamylasemia include pneumonia (increased&#x000a0;salivary amylase), cerebral trauma, burns, abdominal aortic aneurysms (increased pancreatic amylase), drugs (increased salivary and/or pancreatic amylase), anorexia nervosa and bulimia (increased salivary amylase), non-pathological factors (increased salivary and/or pancreatic amylase), and organophosphate poisoning. Post-procedure balloon-assisted enteroscopy has also been associated with elevated amylase levels. Therefore, it is recommended to measure pancreatic amylase levels rather than total amylase levels following these procedures.<xref ref-type="bibr" rid="article-17491.r3">[3]</xref><xref ref-type="bibr" rid="article-17491.r81">[81]</xref>&#x000a0;Elevated pancreatic enzymes can be found in critically injured trauma patients, even in the absence of true pancreatitis.<xref ref-type="bibr" rid="article-17491.r82">[82]</xref></p>
      </sec>
      <sec id="article-17491.s10" sec-type="Quality Control and Lab Safety&#x0000d;&#x0000a;">
        <title>Quality Control and Lab Safety
</title>
        <p>The purpose of a clinical laboratory test is to assess the pathophysiological state of a specific patient, aiding in the process of diagnosis, offering guidance or supervision of treatment, and evaluating the likelihood or advancement of the disease.<xref ref-type="bibr" rid="article-17491.r83">[83]</xref>&#x000a0;Implementing a quality management system (QMS) is paramount in upholding the precision and reliability of laboratory tests.<xref ref-type="bibr" rid="article-17491.r84">[84]</xref> Internal quality control (IQC) is a cornerstone within the QMS of a clinical laboratory, systematically monitoring and verifying the accuracy and precision of laboratory test results.<xref ref-type="bibr" rid="article-17491.r85">[85]</xref></p>
        <p>All aspects of laboratory operation, including IQC, must adhere to written standard operating procedures (SOPs).<xref ref-type="bibr" rid="article-17491.r86">[86]</xref>&#x000a0;The SOP for quality control (QC) should include all aspects of the program, including the selection of QC materials, determination of statistical parameters to describe method performance, criteria for accepting QC results, measurement frequency of QC materials, corrective actions when problems arise, and the documentation and review processes. The SOP should specify authorized personnel responsible for setting acceptable control limits and interpretive rules for result release, reviewing performance parameters, including statistical QC results, and granting authorization for exceptions to or modifications of established QC policies and procedures.<xref ref-type="bibr" rid="article-17491.r87">[87]</xref></p>
        <p>The QC samples are periodically measured using the same method as clinical samples, and the results are analyzed to ensure that the measurement procedure meets performance requirements suitable for patient care.<xref ref-type="bibr" rid="article-17491.r85">[85]</xref>&#x000a0;If the QC result falls within the acceptable limits of the known value, it verifies that the measurement procedure is stable and performing as expected. This indicates that results for patient samples can be reported with a high probability that they are suitable for clinical use. If a QC result falls outside the acceptable limits, it indicates that the measurement procedure is not performing correctly. As a result, patient sample results cannot be reported, and corrective action is necessary. After taking corrective measures, patient sample measurements are repeated, along with QC samples, to ensure accurate and reliable results.<xref ref-type="bibr" rid="article-17491.r88">[88]</xref> Adhering to good laboratory practice involves verifying that a method is performing correctly at the moment when patient results are being measured.<xref ref-type="bibr" rid="article-17491.r89">[89]</xref></p>
        <p>For non-waived tests, laboratory regulations mandate the analysis of a minimum of 2 control material levels at least once every 24 hours. In cases where it is necessary, laboratories may choose to assay QC samples more frequently to ensure the accuracy of results. In addition, it is essential to analyze QC samples after the calibration or maintenance of an analyzer to verify the correct method performance.<xref ref-type="bibr" rid="article-17491.r85">[85]</xref> To reduce the frequency of QC testing for assays that have manufacturer-recommended intervals less frequent than those required by regulatory agencies, such as once per month, laboratories have the option to implement an individualized&#x000a0;QC plan (IQCP). This plan includes a risk assessment, which evaluates potential sources of errors across all testing phases, and the implementation of a tailored QC strategy to minimize the risk of errors.<xref ref-type="bibr" rid="article-17491.r90">[90]</xref>&#x000a0;Westgard multi-rules are used to assess the&#x000a0;QC runs. In case of a rule violation, appropriate corrective and preventive actions must be executed before patient testing.<xref ref-type="bibr" rid="article-17491.r91">[91]</xref></p>
        <p>Proficiency testing (PT) is a program designed to assess method performance by comparing results with those from other laboratories analyzing the same set of samples.<xref ref-type="bibr" rid="article-17491.r92">[92]</xref>&#x000a0;PT providers distribute a set of samples among a group of laboratories for this purpose. Each laboratory analyzes the PT samples in the same manner as they would with patient samples and then reports the results to the PT provider for evaluation. The PT provider assigns a target value to the samples and evaluates whether the individual laboratory's results align closely with the target value, indicating acceptable method performance.<xref ref-type="bibr" rid="article-17491.r93">[93]</xref> The acceptable performance criteria for amylase assay, as defined by the Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) proficiency program, are within &#x000b1;30% of the mean value of laboratory peer groups.<xref ref-type="bibr" rid="article-17491.r94">[94]</xref></p>
        <p>If an unacceptable PT result is identified, the method must be investigated for possible causes, and any necessary corrective action must be taken.<xref ref-type="bibr" rid="article-17491.r95">[95]</xref> Furthermore, even when a PT result is within acceptability criteria, it is good laboratory practice to investigate PT results that deviate by more than approximately 2.5 standard deviation index (SDI) from the peer group mean. When the SDI is 2.5, there is only a 0.6% probability that the result will fall within the expected distribution for the peer group. Therefore, it is reasonable to suspect that a method problem may need to be corrected.<xref ref-type="bibr" rid="article-17491.r96">[96]</xref>&#x000a0;Investigative steps, reviewed data, and conclusions derived from the review must be documented in a written report of the unacceptable PT result, which the Director of the laboratory should review.<xref ref-type="bibr" rid="article-17491.r93">[93]</xref></p>
        <p>Ensuring lab safety is paramount in clinical laboratories, where precise and reliable results are essential for patient diagnoses and treatment plans.<xref ref-type="bibr" rid="article-17491.r97">[97]</xref> Maintaining a secure environment requires strict adherence to safety protocols. This includes using personal protective equipment (PPE), including lab coats, gloves, goggles, and masks, to protect against potential hazards.<xref ref-type="bibr" rid="article-17491.r98">[98]</xref>&#x000a0;Chemical safety measures include appropriate labeling, storage, and handling of chemicals, ensuring that hazardous substances are stored in designated areas. Similarly, biological safety is of utmost importance, requiring the use of biosafety cabinets and stringent protocols for managing potentially infectious materials. Regular maintenance and calibration of equipment, as well as staff training on safe operation, are crucial in preventing accidents and ensuring accurate results. In case of emergencies, it is essential to have well-defined procedures for handling accidents, spills, or exposures, along with a clear understanding of the locations of safety equipment and evacuation routes.<xref ref-type="bibr" rid="article-17491.r99">[99]</xref>&#x000a0;</p>
        <p>Fire safety precautions, including the availability of fire extinguishers and proper storage of flammable materials, are of utmost importance. In addition, electrical safety measures, such as equipment maintenance and ensuring proper grounding, help prevent electrical hazards.<xref ref-type="bibr" rid="article-17491.r100">[100]</xref>&#x000a0;Safe handling and disposal of sharps and appropriate management of chemical and biohazardous waste are essential to protect lab personnel. Rigorous training on safety protocols, in addition to comprehensive documentation of incidents, procedures, and training, fosters a culture of safety and ensures compliance with regulatory standards.<xref ref-type="bibr" rid="article-17491.r101">[101]</xref> In conclusion, a comprehensive approach to lab safety is indispensable for preserving both the accuracy of test results and the well-being of laboratory personnel in clinical settings.&#x000a0;</p>
      </sec>
      <sec id="article-17491.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Effective communication among interprofessional healthcare team members is crucial when laboratory results indicate a potential non-pancreatic cause for amylase level abnormalities. Moreover, it is equally important for the healthcare team to understand how various conditions can affect amylase levels.<xref ref-type="bibr" rid="article-17491.r102">[102]</xref> Lipase is generally favored over amylase because of its greater specificity. Lipase levels usually stay elevated for up to 2 weeks, whereas amylase concentrations tend to return to normal within 5 days. Therefore, in cases where there is a gap between symptom onset and the patient seeking medical attention, amylase is less clinically valuable compared to lipase.<xref ref-type="bibr" rid="article-17491.r18">[18]</xref></p>
        <p>The 2013 American College of Gastroenterology guidelines highlight that simultaneously ordering both lipase and amylase is neither cost-effective nor therapeutically advantageous. Furthermore, the healthcare providers emphasize that ordering amylase alone is an unreliable approach and does not enhance diagnostic efficiency compared to lipase.<xref ref-type="bibr" rid="article-17491.r12">[12]</xref>&#x000a0;Hence, when lipase testing is available, including amylase testing not only increases the cost for the patient but also provides minimal value in aiding the diagnosis of pancreatitis.<xref ref-type="bibr" rid="article-17491.r103">[103]</xref></p>
      </sec>
      <sec id="article-17491.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17491&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17491">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17491/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17491">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17491.s13">
        <title>References</title>
        <ref id="article-17491.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pieper-Bigelow</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Strocchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Levitt</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Where does serum amylase come from and where does it go?</article-title>
            <source>Gastroenterol Clin North Am</source>
            <year>1990</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>793</fpage>
            <page-range>793-810</page-range>
            <pub-id pub-id-type="pmid">1702756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zakowski</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Bruns</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Biochemistry of human alpha amylase isoenzymes.</article-title>
            <source>Crit Rev Clin Lab Sci</source>
            <year>1985</year>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>283</fpage>
            <page-range>283-322</page-range>
            <pub-id pub-id-type="pmid">2578342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azzopardi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Conlan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Whitaker</surname>
                <given-names>IS</given-names>
              </name>
            </person-group>
            <article-title>Clinical applications of amylase: Novel perspectives.</article-title>
            <source>Surgery</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>160</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-37</page-range>
            <pub-id pub-id-type="pmid">27117578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reynolds</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Amylase.</article-title>
            <source>Br J Hosp Med (Lond)</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>70</volume>
            <issue>1</issue>
            <fpage>M8</fpage>
            <page-range>M8-9</page-range>
            <pub-id pub-id-type="pmid">19357566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chase</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Serum amylase and lipase in the evaluation of acute abdominal pain.</article-title>
            <source>Am Surg</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>62</volume>
            <issue>12</issue>
            <fpage>1028</fpage>
            <page-range>1028-33</page-range>
            <pub-id pub-id-type="pmid">8955242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Argiris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mathur-Wagh</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Wilets</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mildvan</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Abnormalities of serum amylase and lipase in HIV-positive patients.</article-title>
            <source>Am J Gastroenterol</source>
            <year>1999</year>
            <month>May</month>
            <volume>94</volume>
            <issue>5</issue>
            <fpage>1248</fpage>
            <page-range>1248-52</page-range>
            <pub-id pub-id-type="pmid">10235202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pezzilli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Andreone</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Morselli-Labate</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Sama</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Billi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cursaro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barakat</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gramenzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fiocchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miglio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bernardi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Serum pancreatic enzyme concentrations in chronic viral liver diseases.</article-title>
            <source>Dig Dis Sci</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>350</fpage>
            <page-range>350-5</page-range>
            <pub-id pub-id-type="pmid">10063922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rizvi</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Serum amylase and lipase in diabetic ketoacidosis.</article-title>
            <source>Diabetes Care</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>26</volume>
            <issue>11</issue>
            <fpage>3193</fpage>
            <page-range>3193-4</page-range>
            <pub-id pub-id-type="pmid">14578269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muniraj</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pitchumoni</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>PANCREATITIS OR NOT?--Elevated lipase and amylase in ICU patients.</article-title>
            <source>J Crit Care</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>1370</fpage>
            <page-range>1370-5</page-range>
            <pub-id pub-id-type="pmid">26411523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lenler-Petersen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Grove</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brock</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jelnes</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>alpha-Amylase in resectable lung cancer.</article-title>
            <source>Eur Respir J</source>
            <year>1994</year>
            <month>May</month>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>941</fpage>
            <page-range>941-5</page-range>
            <pub-id pub-id-type="pmid">8050552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldberg</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Spooner</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Amylase, isoamylase and macroamylase.</article-title>
            <source>Digestion</source>
            <year>1975</year>
            <volume>13</volume>
            <issue>1-2</issue>
            <fpage>56</fpage>
            <page-range>56-75</page-range>
            <pub-id pub-id-type="pmid">1104398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barbieri</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Riggio</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Jaffe</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Amylase testing for abdominal pain and suspected acute pancreatitis.</article-title>
            <source>J Hosp Med</source>
            <year>2016</year>
            <month>May</month>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>366</fpage>
            <page-range>366-8</page-range>
            <pub-id pub-id-type="pmid">27160507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Motoo</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>[Amylase].</article-title>
            <source>Nihon Rinsho</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>62 Suppl 11</volume>
            <fpage>387</fpage>
            <page-range>387-9</page-range>
            <pub-id pub-id-type="pmid">15628424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peyrot des Gachons</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Breslin</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Salivary Amylase: Digestion and Metabolic Syndrome.</article-title>
            <source>Curr Diab Rep</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>10</issue>
            <fpage>102</fpage>
            <pub-id pub-id-type="pmid">27640169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Otsuki</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Usefulness of amylase isoenzyme determination for the diagnosis of pancreatic diseases].</article-title>
            <source>Nihon Rinsho</source>
            <year>1995</year>
            <month>May</month>
            <volume>53</volume>
            <issue>5</issue>
            <fpage>1184</fpage>
            <page-range>1184-91</page-range>
            <pub-id pub-id-type="pmid">7541479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berk</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Fridhandler</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Clinical application of amylase isoenzyme analysis.</article-title>
            <source>Am J Gastroenterol</source>
            <year>1975</year>
            <month>Jun</month>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>457</fpage>
            <page-range>457-63</page-range>
            <pub-id pub-id-type="pmid">1146802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brault</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bonnefoy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Houry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dreux</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bunodi&#x000e8;re</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Huguier</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Acute pancreatitis and biochemical markers. Isoamylase].</article-title>
            <source>Pathol Biol (Paris)</source>
            <year>1985</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>195</fpage>
            <page-range>195-9</page-range>
            <pub-id pub-id-type="pmid">2409510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rompianesi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Komolafe</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Gurusamy</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Apr</month>
            <day>21</day>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>CD012010</fpage>
            <pub-id pub-id-type="pmid">28431198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ismail</surname>
                <given-names>OZ</given-names>
              </name>
              <name>
                <surname>Bhayana</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Lipase or amylase for the diagnosis of acute pancreatitis?</article-title>
            <source>Clin Biochem</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>50</volume>
            <issue>18</issue>
            <fpage>1275</fpage>
            <page-range>1275-1280</page-range>
            <pub-id pub-id-type="pmid">28720341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giavarina</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Blood venous sample collection: Recommendations overview and a checklist to improve quality.</article-title>
            <source>Clin Biochem</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>50</volume>
            <issue>10-11</issue>
            <fpage>568</fpage>
            <page-range>568-573</page-range>
            <pub-id pub-id-type="pmid">28242283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>von Meyer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cadamuro</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Simundic</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Blood sample quality.</article-title>
            <source>Diagnosis (Berl)</source>
            <year>2019</year>
            <month>Mar</month>
            <day>26</day>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-31</page-range>
            <pub-id pub-id-type="pmid">29794250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>King</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Seelig</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Ranney</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>The lipase to amylase ratio in acute pancreatitis.</article-title>
            <source>Am J Gastroenterol</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>90</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <page-range>67-9</page-range>
            <pub-id pub-id-type="pmid">7528469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lankisch</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lipase/amylase ratio: not helpful in the early etiological differentiation of acute pancreatitis.</article-title>
            <source>Z Gastroenterol</source>
            <year>1994</year>
            <month>Jan</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-11</page-range>
            <pub-id pub-id-type="pmid">7511857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oshina</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Spigulis</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Beer-Lambert law for optical tissue diagnostics: current state of the art and the main limitations.</article-title>
            <source>J Biomed Opt</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">34713647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000e4;ntele</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Deniz</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>UV-VIS absorption spectroscopy: Lambert-Beer reloaded.</article-title>
            <source>Spectrochim Acta A Mol Biomol Spectrosc</source>
            <year>2017</year>
            <month>Feb</month>
            <day>15</day>
            <volume>173</volume>
            <fpage>965</fpage>
            <page-range>965-968</page-range>
            <pub-id pub-id-type="pmid">27727137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gromashevskaia</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Bogatyr'</surname>
                <given-names>TV</given-names>
              </name>
            </person-group>
            <article-title>[Serum amylase isoenzymes: their sources and clinical value of their determination (review of the literature)].</article-title>
            <source>Lab Delo</source>
            <year>1986</year>
            <issue>8</issue>
            <fpage>451</fpage>
            <page-range>451-7</page-range>
            <pub-id pub-id-type="pmid">2429044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takagi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>[Methods of serum enzyme determination and its clinical significance: amylase inhibitors--with special reference to their application in the quantitative analysis of amylase isoenzymes in the human body fluids].</article-title>
            <source>Rinsho Byori</source>
            <year>1983</year>
            <month>Jun</month>
            <volume>Suppl 55</volume>
            <fpage>61</fpage>
            <page-range>61-8</page-range>
            <pub-id pub-id-type="pmid">6197542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamdan</surname>
                <given-names>II</given-names>
              </name>
              <name>
                <surname>Afifi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Taha</surname>
                <given-names>MO</given-names>
              </name>
            </person-group>
            <article-title>In vitro alpha amylase inhibitory effect of some clinically-used drugs.</article-title>
            <source>Pharmazie</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>59</volume>
            <issue>10</issue>
            <fpage>799</fpage>
            <page-range>799-801</page-range>
            <pub-id pub-id-type="pmid">15544061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klonoff</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Macroamylasemia and other immunoglobulin-complexed enzyme disorders.</article-title>
            <source>West J Med</source>
            <year>1980</year>
            <month>Nov</month>
            <volume>133</volume>
            <issue>5</issue>
            <fpage>392</fpage>
            <page-range>392-407</page-range>
            <pub-id pub-id-type="pmid">6162278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiederkehr</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Wiederkehr</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Wiederkehr</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Nonspecific hyperamylasemia: a case report.</article-title>
            <source>JOP</source>
            <year>2013</year>
            <month>Jan</month>
            <day>10</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>74</fpage>
            <page-range>74-6</page-range>
            <pub-id pub-id-type="pmid">23306339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cutolo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sulli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Picciotto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mangraviti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seriolo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Accardo</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Macroamylasemia: a possible cause of unexplained hyperamylasemia in rheumatoid arthritis.</article-title>
            <source>Br J Rheumatol</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>290</fpage>
            <page-range>290-2</page-range>
            <pub-id pub-id-type="pmid">7537158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ishizuka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yasuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kajita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sakata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miura</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Macroamylasemia associated with thyroid cancer, elevated serum thyroxine-binding globulin (TBG), chronic pancreatitis and gastrointestinal polyposis.</article-title>
            <source>Gastroenterol Jpn</source>
            <year>1986</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>385</fpage>
            <page-range>385-90</page-range>
            <pub-id pub-id-type="pmid">2429888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r33">
          <label>33</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Lam</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Muniraj</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <chapter-title>Hyperamylasemia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>12</month>
            <day>11</day>
            <pub-id pub-id-type="pmid">32644699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peng</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Goyal</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Serum amylase activity altered by the ABO blood group system in Chinese subjects.</article-title>
            <source>J Clin Lab Anal</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>e22883</fpage>
            <pub-id pub-id-type="pmid">30938472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santos</surname>
                <given-names>SVMD</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>LAD</given-names>
              </name>
              <name>
                <surname>Terra</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Souza</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Espindola</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Marziale</surname>
                <given-names>MHP</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Robazzi</surname>
                <given-names>MLDCC</given-names>
              </name>
            </person-group>
            <article-title>Association of salivary alpha-amylase with anxiety and stress in nursing professionals.</article-title>
            <source>Rev Lat Am Enfermagem</source>
            <year>2021</year>
            <volume>29</volume>
            <fpage>e3468</fpage>
            <pub-id pub-id-type="pmid">34468625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Melnick</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nazir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gish</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Aryal</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Hypertriglyceridemic pancreatitis associated with confounding laboratory abnormalities.</article-title>
            <source>J Community Hosp Intern Med Perspect</source>
            <year>2016</year>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>31808</fpage>
            <pub-id pub-id-type="pmid">27406459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gr&#x000e4;sbeck</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Reference values, why and how.</article-title>
            <source>Scand J Clin Lab Invest Suppl</source>
            <year>1990</year>
            <volume>201</volume>
            <fpage>45</fpage>
            <page-range>45-53</page-range>
            <pub-id pub-id-type="pmid">2244183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bretz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cortina-Borja</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Reference range: Which statistical intervals to use?</article-title>
            <source>Stat Methods Med Res</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>523</fpage>
            <page-range>523-534</page-range>
            <pub-id pub-id-type="pmid">33054684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Miyamura</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Racial/Ethnic-Specific Reference Intervals for Common Laboratory Tests: A Comparison among Asians, Blacks, Hispanics, and White.</article-title>
            <source>Hawaii J Med Public Health</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>74</volume>
            <issue>9</issue>
            <fpage>302</fpage>
            <page-range>302-10</page-range>
            <pub-id pub-id-type="pmid">26468426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gillard</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Simbala</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Goodglick</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Reference intervals for amylase isoenzymes in serum and plasma of infants and children.</article-title>
            <source>Clin Chem</source>
            <year>1983</year>
            <month>Jun</month>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>1119</fpage>
            <page-range>1119-23</page-range>
            <pub-id pub-id-type="pmid">6189641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morgenstern</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Niessen</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Teufel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Value of isoamylases in the diagnosis of exocrine pancreatic insufficiency in childhood].</article-title>
            <source>Monatsschr Kinderheilkd</source>
            <year>1984</year>
            <month>Sep</month>
            <volume>132</volume>
            <issue>9</issue>
            <fpage>661</fpage>
            <page-range>661-5</page-range>
            <pub-id pub-id-type="pmid">6208482</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Furey</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Buxbaum</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chambliss</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>A review of biomarker utilization in the diagnosis and management of acute pancreatitis reveals amylase ordering is favored in patients requiring laparoscopic cholecystectomy.</article-title>
            <source>Clin Biochem</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>77</volume>
            <fpage>54</fpage>
            <page-range>54-56</page-range>
            <pub-id pub-id-type="pmid">31899279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakajima</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Low serum amylase and obesity, diabetes and metabolic syndrome: A novel interpretation.</article-title>
            <source>World J Diabetes</source>
            <year>2016</year>
            <month>Mar</month>
            <day>25</day>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>112</fpage>
            <page-range>112-21</page-range>
            <pub-id pub-id-type="pmid">27022442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakajima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nemoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Muneyuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kakei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fuchigami</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Munakata</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Low serum amylase in association with metabolic syndrome and diabetes: A community-based study.</article-title>
            <source>Cardiovasc Diabetol</source>
            <year>2011</year>
            <month>Apr</month>
            <day>17</day>
            <volume>10</volume>
            <fpage>34</fpage>
            <pub-id pub-id-type="pmid">21496338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Banks</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Sidi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gelman</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Warshaw</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Amylase-creatinine clearance ratios and serum amylase isoenzymes in moderate renal insufficiency.</article-title>
            <source>J Clin Gastroenterol</source>
            <year>1979</year>
            <month>Dec</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>331</fpage>
            <page-range>331-5</page-range>
            <pub-id pub-id-type="pmid">95609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terui</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hishiki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mitsunaga</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Urinary amylase/urinary creatinine ratio (uAm/uCr)--a less-invasive parameter for management of hyperamylasemia.</article-title>
            <source>BMC Pediatr</source>
            <year>2013</year>
            <month>Dec</month>
            <day>13</day>
            <volume>13</volume>
            <fpage>205</fpage>
            <pub-id pub-id-type="pmid">24330759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hansen</surname>
                <given-names>SEJ</given-names>
              </name>
              <name>
                <surname>Langsted</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Varbo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Madsen</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Tybj&#x000e6;rg-Hansen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nordestgaard</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Low and high pancreatic amylase is associated with pancreatic cancer and chronic pancreatitis.</article-title>
            <source>Eur J Epidemiol</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>9</issue>
            <fpage>975</fpage>
            <page-range>975-984</page-range>
            <pub-id pub-id-type="pmid">34482515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boybeyi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Erg&#x000fc;r</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Dursun</surname>
                <given-names>ZE</given-names>
              </name>
              <name>
                <surname>G&#x000fc;lerman</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Amylase/creatinine clearance ratio in diabetic ketoacidosis: a case report.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>27</volume>
            <issue>11-12</issue>
            <fpage>1243</fpage>
            <page-range>1243-5</page-range>
            <pub-id pub-id-type="pmid">25153214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Treacy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bais</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Willson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Worthley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reece</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bessell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of amylase and lipase in the diagnosis of acute pancreatitis.</article-title>
            <source>ANZ J Surg</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>71</volume>
            <issue>10</issue>
            <fpage>577</fpage>
            <page-range>577-82</page-range>
            <pub-id pub-id-type="pmid">11552931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Southwell-Keely</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chesher</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Should serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis?</article-title>
            <source>ANZ J Surg</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>75</volume>
            <issue>6</issue>
            <fpage>399</fpage>
            <page-range>399-404</page-range>
            <pub-id pub-id-type="pmid">15943725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>ZX</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Lipase and pancreatic amylase activities in diagnosis of acute pancreatitis in patients with hyperamylasemia.</article-title>
            <source>Hepatobiliary Pancreat Dis Int</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>600</fpage>
            <page-range>600-3</page-range>
            <pub-id pub-id-type="pmid">16286272</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashraf</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Marcucci</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rhoton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Olowoyo</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>A Clinical Overview of Acute and Chronic Pancreatitis: The Medical and Surgical Management.</article-title>
            <source>Cureus</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>13</volume>
            <issue>11</issue>
            <fpage>e19764</fpage>
            <pub-id pub-id-type="pmid">34938639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pham</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Forsmark</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Chronic pancreatitis: review and update of etiology, risk factors, and management.</article-title>
            <source>F1000Res</source>
            <year>2018</year>
            <volume>7</volume>
            <pub-id pub-id-type="pmid">29946424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hiele</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ghoos</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Rutgeerts</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vantrappen</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro.</article-title>
            <source>Dig Dis Sci</source>
            <year>1992</year>
            <month>Jul</month>
            <volume>37</volume>
            <issue>7</issue>
            <fpage>1057</fpage>
            <page-range>1057-64</page-range>
            <pub-id pub-id-type="pmid">1618053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garrison</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Amylase.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>1986</year>
            <month>May</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>315</fpage>
            <page-range>315-27</page-range>
            <pub-id pub-id-type="pmid">2422011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hiatt</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Calabria</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Passaro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>The amylase profile: a discriminant in biliary and pancreatic disease.</article-title>
            <source>Am J Surg</source>
            <year>1987</year>
            <month>Nov</month>
            <volume>154</volume>
            <issue>5</issue>
            <fpage>490</fpage>
            <page-range>490-2</page-range>
            <pub-id pub-id-type="pmid">2445215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeong</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Amylase level in extrahepatic bile duct in adult patients with choledochal cyst plus anomalous pancreatico-biliary ductal union.</article-title>
            <source>World J Gastroenterol</source>
            <year>2005</year>
            <month>Apr</month>
            <day>07</day>
            <volume>11</volume>
            <issue>13</issue>
            <fpage>1965</fpage>
            <page-range>1965-70</page-range>
            <pub-id pub-id-type="pmid">15800987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collen</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ansher</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Mackow</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Serum amylase in patients with renal insufficiency and renal failure.</article-title>
            <source>Am J Gastroenterol</source>
            <year>1990</year>
            <month>Oct</month>
            <volume>85</volume>
            <issue>10</issue>
            <fpage>1377</fpage>
            <page-range>1377-80</page-range>
            <pub-id pub-id-type="pmid">1699413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mizuno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hanamura</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ota</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karnan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Narita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mizutani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gotou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsunekawa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shikami</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iida</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hosokawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miwa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ueda</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nitta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takami</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells.</article-title>
            <source>Int J Hematol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>102</volume>
            <issue>5</issue>
            <fpage>569</fpage>
            <page-range>569-78</page-range>
            <pub-id pub-id-type="pmid">26341959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shigemura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moriyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shibuya</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Obara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Endo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hashino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yokouchi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Asaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chiba</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Multiple myeloma associated with sialyl salivary-type amylase.</article-title>
            <source>Clin Chim Acta</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>376</volume>
            <issue>1-2</issue>
            <fpage>121</fpage>
            <page-range>121-5</page-range>
            <pub-id pub-id-type="pmid">16979610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ross</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Devgun</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Gunn</surname>
                <given-names>IR</given-names>
              </name>
            </person-group>
            <article-title>Hyperamylasaemia and multiple myeloma.</article-title>
            <source>Ann Clin Biochem</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>39</volume>
            <issue>Pt 6</issue>
            <fpage>616</fpage>
            <page-range>616-20</page-range>
            <pub-id pub-id-type="pmid">12564849</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Romanczuk</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ruptured ectopic pregnancy mimicking acute pancreatitis.</article-title>
            <source>Ginekol Pol</source>
            <year>2009</year>
            <month>May</month>
            <volume>80</volume>
            <issue>5</issue>
            <fpage>383</fpage>
            <page-range>383-5</page-range>
            <pub-id pub-id-type="pmid">19548460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Gardner</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Paraganglioma with acute hyperamylasaemia masquerading as acute pancreatitis.</article-title>
            <source>Singapore Med J</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>52</volume>
            <issue>12</issue>
            <fpage>e251</fpage>
            <page-range>e251-4</page-range>
            <pub-id pub-id-type="pmid">22159946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arifi</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Yim</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Is hyperamylasemia after cardiac surgery due to cardiopulmonary bypass?</article-title>
            <source>Asian Cardiovasc Thorac Ann</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>115</fpage>
            <page-range>115-8</page-range>
            <pub-id pub-id-type="pmid">12079932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gullo</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Benign pancreatic hyperenzymemia.</article-title>
            <source>Dig Liver Dis</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>698</fpage>
            <page-range>698-702</page-range>
            <pub-id pub-id-type="pmid">17531557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Birtolo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Migliori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Drewes</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Tomassetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Imbrogno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fusaroli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Casadei</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ricci</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stanghellini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>De Giorgio</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Benign Pancreatic Hyperenzymemia: Lights on a Clinical Challenge.</article-title>
            <source>Pancreas</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>46</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-7</page-range>
            <pub-id pub-id-type="pmid">27977626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pezzilli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Barassi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morselli-Labate</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Fantini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tomassetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Campana</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Casadei</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Finazzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>d'Eril</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Corinaldesi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation.</article-title>
            <source>J Gastroenterol</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>9</issue>
            <fpage>754</fpage>
            <page-range>754-60</page-range>
            <pub-id pub-id-type="pmid">17876545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bloch</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Weaver</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Bouwman</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Alcohol-induced salivary hyperamylasemia.</article-title>
            <source>J Surg Res</source>
            <year>1984</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>389</fpage>
            <page-range>389-94</page-range>
            <pub-id pub-id-type="pmid">6200693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheutzel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gerlach</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>[Alpha-amylase isoenzymes in serum and saliva of patients with anorexia and bulimia nervosa].</article-title>
            <source>Z Gastroenterol</source>
            <year>1991</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>7</issue>
            <fpage>339</fpage>
            <page-range>339-45</page-range>
            <pub-id pub-id-type="pmid">1950041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Monteleone</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Scognamiglio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Monteleone</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mastromo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Steardo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Serino</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Maj</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Abnormal diurnal patterns of salivary &#x003b1;-amylase and cortisol secretion in acute patients with anorexia nervosa.</article-title>
            <source>World J Biol Psychiatry</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>455</fpage>
            <page-range>455-61</page-range>
            <pub-id pub-id-type="pmid">21745126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamamoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kuroda</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Amylase producing tumor].</article-title>
            <source>Ryoikibetsu Shokogun Shirizu</source>
            <year>1994</year>
            <issue>4</issue>
            <fpage>17</fpage>
            <page-range>17-9</page-range>
            <pub-id pub-id-type="pmid">7516440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vukovi&#x00107;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kuna</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lon&#x0010d;ar Brzak</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vu&#x0010d;i&#x0010d;evi&#x00107; Boras</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>&#x00160;eparovi&#x00107;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>&#x00160;ekerija</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>&#x00160;umilin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vidranski</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>THE ROLE OF SALIVARY AND SERUM CA125 AND ROUTINE BLOOD TESTS IN PATIENTS WITH OVARIAN MALIGNANCIES.</article-title>
            <source>Acta Clin Croat</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>60</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-62</page-range>
            <pub-id pub-id-type="pmid">34588722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Otsuki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yuu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Maeda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saeki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yamasaki</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Amylase in the lung.</article-title>
            <source>Cancer</source>
            <year>1977</year>
            <month>Apr</month>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>1656</fpage>
            <page-range>1656-63</page-range>
            <pub-id pub-id-type="pmid">856449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zhen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Amylase: sensitive tumor marker for amylase-producing lung adenocarcinoma.</article-title>
            <source>J Thorac Dis</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>E167</fpage>
            <page-range>E167-9</page-range>
            <pub-id pub-id-type="pmid">23991331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lv</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rong</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Hyperamylasemia may indicate the presence of ovarian carcinoma: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>97</volume>
            <issue>49</issue>
            <fpage>e13520</fpage>
            <pub-id pub-id-type="pmid">30544453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Obiekwe</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Chard</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>What do placental function tests predict? Observations on placental lactogen levels in growth retardation and fetal distress.</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>1982</year>
            <month>Nov</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>69</fpage>
            <page-range>69-73</page-range>
            <pub-id pub-id-type="pmid">7173482</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chandra</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bsavaraju</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mr</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Av</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>R</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Serum Amylase and Lipase Estimation in Diabetic Ketoacidosis.</article-title>
            <source>J Assoc Physicians India</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>11</fpage>
            <page-range>11-12</page-range>
            <pub-id pub-id-type="pmid">35443366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Serene</surname>
                <given-names>TEL</given-names>
              </name>
              <name>
                <surname>G</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Padmakumar</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Terence</surname>
                <given-names>HCW</given-names>
              </name>
              <name>
                <surname>Keem</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Bei</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Winston</surname>
                <given-names>WWL</given-names>
              </name>
            </person-group>
            <article-title>Predictive value of post-operative drain amylase levels for post-operative pancreatic fistula.</article-title>
            <source>Ann Hepatobiliary Pancreat Surg</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>397</fpage>
            <page-range>397-404</page-range>
            <pub-id pub-id-type="pmid">30588532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kasapo&#x0011f;lu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ozmen</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Co&#x0015f;kun</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Eri&#x0015f;en</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Onart</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of amylase levels in the neck drainage and serum for early diagnosis of the pharyngocutaneous fistula.</article-title>
            <source>Kulak Burun Bogaz Ihtis Derg</source>
            <year>2009</year>
            <season>Mar-Apr</season>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>67</fpage>
            <page-range>67-70</page-range>
            <pub-id pub-id-type="pmid">19796002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Medeiros</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Silveira</surname>
                <given-names>VA</given-names>
              </name>
            </person-group>
            <article-title>Clinical and subclinical pancreatitis in a cohort of patients diagnosed with systemic lupus erythematosus.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2011</year>
            <season>Sep-Oct</season>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>776</fpage>
            <page-range>776-82</page-range>
            <pub-id pub-id-type="pmid">21962107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kop&#x000e1;&#x0010d;ov&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bure&#x00161;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rejchrt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>V&#x000e1;vrov&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>B&#x000e1;rtov&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Soukup</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tom&#x00161;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tachec&#x000ed;</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Risk Factors of Acute Pancreatitis in Oral Double Balloon Enteroscopy.</article-title>
            <source>Acta Medica (Hradec Kralove)</source>
            <year>2016</year>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>84</fpage>
            <page-range>84-90</page-range>
            <pub-id pub-id-type="pmid">27638962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Guire</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Burd</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Mooney</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Ehlrich</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Utility of amylase and lipase as predictors of grade of injury or outcomes in pediatric patients with pancreatic trauma.</article-title>
            <source>J Pediatr Surg</source>
            <year>2011</year>
            <month>May</month>
            <volume>46</volume>
            <issue>5</issue>
            <fpage>923</fpage>
            <page-range>923-6</page-range>
            <pub-id pub-id-type="pmid">21616253</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r83">
          <label>83</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bayot</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Naidoo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Clinical Laboratory</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>12</month>
            <day>19</day>
            <pub-id pub-id-type="pmid">30570979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wadhwa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thukral</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chopra</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Laboratory quality management system: road to accreditation and beyond.</article-title>
            <source>Indian J Med Microbiol</source>
            <year>2012</year>
            <season>Apr-Jun</season>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>131</fpage>
            <page-range>131-40</page-range>
            <pub-id pub-id-type="pmid">22664426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kinns</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pitkin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Housley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Freedman</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Internal quality control: best practice.</article-title>
            <source>J Clin Pathol</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>66</volume>
            <issue>12</issue>
            <fpage>1027</fpage>
            <page-range>1027-32</page-range>
            <pub-id pub-id-type="pmid">24072731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Westgard</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>Internal quality control: planning and implementation strategies.</article-title>
            <source>Ann Clin Biochem</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>40</volume>
            <issue>Pt 6</issue>
            <fpage>593</fpage>
            <page-range>593-611</page-range>
            <pub-id pub-id-type="pmid">14629798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skitek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martinello</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jerin</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>How to Really Understand and Improve the System of Internal Quality Control and External Quality Assessment in the Accreditation Process of the Medical Laboratory?</article-title>
            <source>EJIFCC</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-27</page-range>
            <pub-id pub-id-type="pmid">35645692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mishra</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>BKL</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Gelal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Niraula</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chaudhari</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Lamsal</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Knowledge of Internal Quality Control for Laboratory Tests among Laboratory Personnel Working in Department of Biochemistry in a Tertiary Care Center: A Descriptive Cross-sectional Study.</article-title>
            <source>JNMA J Nepal Med Assoc</source>
            <year>2023</year>
            <month>Feb</month>
            <day>01</day>
            <volume>61</volume>
            <issue>258</issue>
            <fpage>167</fpage>
            <page-range>167-170</page-range>
            <pub-id pub-id-type="pmid">37203967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nichols</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Verification of method performance for clinical laboratories.</article-title>
            <source>Adv Clin Chem</source>
            <year>2009</year>
            <volume>47</volume>
            <fpage>121</fpage>
            <page-range>121-37</page-range>
            <pub-id pub-id-type="pmid">19634779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kearney</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Internal quality control.</article-title>
            <source>Methods Mol Biol</source>
            <year>2013</year>
            <volume>1065</volume>
            <fpage>277</fpage>
            <page-range>277-89</page-range>
            <pub-id pub-id-type="pmid">23996371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bayat</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Selecting multi-rule quality control procedures based on patient risk.</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2017</year>
            <month>Oct</month>
            <day>26</day>
            <volume>55</volume>
            <issue>11</issue>
            <fpage>1702</fpage>
            <page-range>1702-1708</page-range>
            <pub-id pub-id-type="pmid">28236626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Horowitz</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Weykamp</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Proficiency testing/external quality assessment: current challenges and future directions.</article-title>
            <source>Clin Chem</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>57</volume>
            <issue>12</issue>
            <fpage>1670</fpage>
            <page-range>1670-80</page-range>
            <pub-id pub-id-type="pmid">21965556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shahangian</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Proficiency testing in laboratory medicine: uses and limitations.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>122</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-30</page-range>
            <pub-id pub-id-type="pmid">9448012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laubender</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Geistanger</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Selection of within-run quality control rules for laboratory biomarkers.</article-title>
            <source>Stat Med</source>
            <year>2021</year>
            <month>Jul</month>
            <day>20</day>
            <volume>40</volume>
            <issue>16</issue>
            <fpage>3645</fpage>
            <page-range>3645-3666</page-range>
            <pub-id pub-id-type="pmid">33876446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kristensen</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Meijer</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Interpretation of EQA results and EQA-based trouble shooting.</article-title>
            <source>Biochem Med (Zagreb)</source>
            <year>2017</year>
            <month>Feb</month>
            <day>15</day>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-62</page-range>
            <pub-id pub-id-type="pmid">28392726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Earley</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Astles</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Breckenridge</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Practices and Perceived Value of Proficiency Testing in Clinical Laboratories.</article-title>
            <source>J Appl Lab Med</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>415</fpage>
            <page-range>415-420</page-range>
            <pub-id pub-id-type="pmid">31903445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wagar</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The laboratory and patient safety.</article-title>
            <source>Clin Lab Med</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>909</fpage>
            <page-range>909-30, viii-ix</page-range>
            <pub-id pub-id-type="pmid">17950905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ejilemele</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Ojule</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Health and safety in clinical laboratories in developing countries: safety considerations.</article-title>
            <source>Niger J Med</source>
            <year>2004</year>
            <season>Apr-Jun</season>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>182</fpage>
            <page-range>182-8</page-range>
            <pub-id pub-id-type="pmid">15293842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cornish</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Arambula</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Arduino</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bryan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dickson</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Giri</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Pentella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Salerno</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Sandhu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Snyder</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Tormey</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Wagar</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Weirich</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2021</year>
            <month>Jun</month>
            <day>16</day>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>e0012618</fpage>
            <pub-id pub-id-type="pmid">34105993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adyanthaya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jose</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Quality and safety aspects in histopathology laboratory.</article-title>
            <source>J Oral Maxillofac Pathol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>402</fpage>
            <page-range>402-7</page-range>
            <pub-id pub-id-type="pmid">24574660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ionescu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Negu&#x00163;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Combiescu</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>[Biosafety and biosecurity in the medical laboratory. Update and trends].</article-title>
            <source>Bacteriol Virusol Parazitol Epidemiol</source>
            <year>2007</year>
            <season>Jul-Dec</season>
            <volume>52</volume>
            <issue>3-4</issue>
            <fpage>91</fpage>
            <page-range>91-9</page-range>
            <pub-id pub-id-type="pmid">19326721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Logie</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sharkey</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A multidisciplinary approach to an unusual cause of hyperamylasaemia.</article-title>
            <source>BMJ Case Rep</source>
            <year>2015</year>
            <month>Jul</month>
            <day>06</day>
            <volume>2015</volume>
            <pub-id pub-id-type="pmid">26150631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17491.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beauregard</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Lyon</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Slovis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Using the literature to evaluate diagnostic tests: amylase or lipase for diagnosing acute pancreatitis?</article-title>
            <source>J Med Libr Assoc</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>95</volume>
            <issue>2</issue>
            <fpage>121</fpage>
            <page-range>121-6</page-range>
            <pub-id pub-id-type="pmid">17443244</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
